Back to search
FDAFDA · Food and drugs·Recall number Z-1662-2014

IMPAX CV Pediatric Echo Reporting, IMPAX CV Echo Measurement Import via Optical Character Recognition (OCR) Service IMPAX. For the creation of digital structured reports for cardiovascular diagnostic studies such as echocardiography.

Published June 4, 2014 · Recall initiated: April 30, 2014

Summary

FDA records medical device Class II recall Z-1662-2014, published June 4, 2014 and initiated April 30, 2014. Recalling firm: AGFA Corp.; Status: Terminated; Reported quantity: One; Lot: Model L9M21000 - Software versions: IMPAX CV 7.8 SU3/SU4 - OCR Service. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failure to effectively install and test a hotfix to correct the known software defect within the IMPAX CV 7.8 SU3-OCR Service.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AGFA Corp.
Distributor
Distribution to SC only
Lot
Model L9M21000 - Software versions: IMPAX CV 7.8 SU3/SU4 - OCR Service
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was IMPAX CV Pediatric Echo Reporting, IMPAX CV Echo Measurement Import via Optical Character Recognition (OCR) Service IMPAX. For the creation of digital structured reports for cardiovascular diagnostic studies such as echocardiography. recalled?

Yes. FDA published recall Z-1662-2014 on June 4, 2014. Reported hazard: Failure to effectively install and test a hotfix to correct the known software defect within the IMPAX CV 7.8 SU3-OCR Service.

What should I do if I have this product?

Voluntary: Firm initiated · Letter